Thus the enhanced expression of GFAP, mortalin and NCAM in ASH-WEX-treated cells, in the present study, may suggest the possible mechanism(s) of differentiation inducing potential of Ashwagandha for the treatment of gliomas. Here, HSPA9 is linked to central nervous system cancer.